The Renergen (ASX:RLT) share price is surging 13%. Here's why

The Renergen share price is rocketing today, up 15% in early afternoon trade. We look at what's driving ASX investor interest.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Renergen Limited (ASX: RLT) share price is gaining strongly today, up 13.21% in afternoon trade.

The soaring share price appears to be driven by the helium and natural gas company's ASX release yesterday, after markets closed, announcing the completion and successful operation of its first Cryo-Vacc prototype.

Why is Renergen's Cryo-Vacc launch driving ASX investor interest?

The spike in investor interest in the company's Cryo-Vacc prototype is likely linked to its potential role in delivering COVID-19 vaccines, particularly in developing nations where reliable cold storage facilities are few and far between.

Renergen delivered the prototype to South African-based media in Johannesburg yesterday. The company plans to start production within days.

According to Renergen's release, Cryo-Vacc enables the "efficient transport and storage of ultracold biologics for periods of up to 25 days or longer in transit". This is possible even when there is no external power available. The unit can maintain temperatures in the range of anywhere from -150 ºC to 8ºC, enabling it to support the delivery of a suite of vaccines.

Cryo-Vacc units are also able to give accurate temperature readings of the vaccines during transit, along with GPS tracking.

The units use liquid nitrogen to transport by road and helium to transport by air. Helium is far lighter than nitrogen, and Renergen reported that based on current flight safety regulations, Cryo-Vacc with helium can transport up to 12 times more vials per flight "compared to other cryogens".

In South Africa, Renergen has partnered with local express courier partner, DPD Laser, part of The Laser Group, to distribute vaccines.

Commenting on the rollout of the company's Cryo-Vacc, Renergen's CEO Stefano Marani:

Precise temperature control combined with a formidable hold time in transit, makes Cryo-Vacc a compelling asset in the transport of biologics, especially in the developing world. With a useful temperature range of over 150 ºC, Cryo-Vacc is very versatile when compared to even standard refrigeration technology.

Following the presentation to South African media, Marani added (quoted by Reuters), "We've already started to take orders for this product. So we're ready to start going into production in the next few days."

He added that Renergen has already received numerous queries and order requests from across the globe.

Renergen share price snapshot

With today's intraday gains taken into account, the Renergen share price is up 45% so far in 2021. That compares to a gain of 3% on the All Ordinaries Index (ASX: XAO).

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Why Bell Potter just upgraded this ASX All Ords share to a buy rating

The broker has turned bullish on this growing company. Here's what you need to know.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Bell Potter says these ASX shares are best buys in January

The broker has good things to say about these shares.

Read more »

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Share Market News

Should I invest $1,000 in the VGS ETF?

With $1,000 to invest, diversification matters. This Vanguard ETF provides instant exposure to global markets outside Australia.

Read more »

Close up of a sad young woman reading about declining share price on her phone.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »

ASX board.
Best Shares

The best and worst ASX sectors of the past 12 months

A wide gap opened between the best and worst ASX sectors over the past 12 months.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Market News

5 things to watch on the ASX 200 on Monday

A soft start to the week is expected for Aussie investors.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man holding Australian dollar notes, symbolising dividends.
Dividend Investing

Want to build up passive income? These 2 ASX dividend shares are a buy!

These stocks are giving investors exciting payouts every year.

Read more »